Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 1 | €0.43 | - | - |
| Gritstone Oncology Inc | 3 | 2 | 0 | 2 | €0.68 | €6.53 | 860.441% |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 1 | €0.66 | €3.00 | 357.178% |
| Nymox Pharmaceutical Corp. | 0 | 4 | 0 | 0 | €0.23 | - | - |
| Karyopharm Therapeutics Inc. | 8 | 2 | 1 | 0 | €1.09 | €6.28 | 474.426% |
| Organovo Holdings Inc. | 0 | 5 | 0 | 2 | €1.20 | €3.00 | 150.417% |
| Daiichi Sankyo Co Ltd | 0 | 1 | 0 | 0 | €27.50 | - | - |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 1 | €2.32 | €7.00 | 201.724% |
| Formycon AG | 3 | 1 | 0 | 1 | €43.40 | €100.00 | 130.415% |
| Corvus Pharmaceuticals Inc | 4 | 1 | 2 | 1 | €1.38 | €5.10 | 269.254% |
| Neptune Wellness Solutions Inc | 0 | 15 | 0 | 2 | €0.14 | - | - |
| Coherus Bioscien. | 2 | 2 | 0 | 1 | €2.06 | €3.00 | 45.702% |
| Trevena Inc. | 1 | 14 | 1 | 3 | €0.33 | €8.37 | 2439.120% |
| Biofrontera AG | 0 | 2 | 0 | 1 | €0.32 | €0.000 | -100.000% |
| Ocuphire Pharma Inc. | 5 | 1 | 1 | 1 | €1.66 | €18.30 | 1002.169% |
| Accelerate Diagnostics Inc. | 1 | 1 | 1 | 0 | €0.81 | - | - |
| T2 Biosystems Inc. | 0 | 13 | 0 | 0 | €0.16 | - | - |
| Medigene AG | 0 | 2 | 0 | 1 | €1.95 | €1.00 | -48.718% |
| Sangamo Therapeutics Inc. | 11 | 12 | 2 | 1 | €0.55 | €2.79 | 411.797% |
| Enzo Biochem. Inc. | 0 | 1 | 0 | 0 | €1.08 | - | - |
| Avinger Inc. | 2 | 8 | 1 | 0 | €0.34 | €4.64 | 1272.633% |
| Pacific Biosciences of California Inc. | 8 | 3 | 1 | 0 | €2.23 | €10.36 | 363.782% |
| Palisade Bio Inc. | 1 | 1 | 0 | 1 | €0.34 | €1.38 | 304.279% |
| Tonix Pharmaceuticals Holding Corp. | 2 | 15 | 0 | 1 | €2.82 | €5.03 | 78.387% |
| Enlivex Therapeutics Ltd. | 1 | 2 | 1 | 2 | €1.35 | - | - |